Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenax Therapeutics (TENX) Net Income towards Common Stockholders (2016 - 2026)

Tenax Therapeutics' Net Income towards Common Stockholders history spans 8 years, with the latest figure at -$17.0 million for Q4 2017.

  • On a quarterly basis, Net Income towards Common Stockholders rose 74.78% to -$17.0 million in Q4 2017 year-over-year; TTM through Dec 2017 was -$9.2 million, a 85.63% increase, with the full-year FY2025 number at -$52.6 million, down 198.62% from a year prior.
  • Net Income towards Common Stockholders hit -$17.0 million in Q4 2017 for Tenax Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for TENX hit a ceiling of $40.2 million in Q2 2014 and a floor of -$67.5 million in Q4 2016.
  • Historically, Net Income towards Common Stockholders has averaged -$819618.4 across 5 years, with a median of $2.6 million in 2013.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 1327.53% in 2014 and later tumbled 770.72% in 2016.
  • Tracing TENX's Net Income towards Common Stockholders over 5 years: stood at $6.1 million in 2013, then crashed by 33.34% to $4.1 million in 2014, then soared by 148.29% to $10.1 million in 2015, then tumbled by 770.72% to -$67.5 million in 2016, then soared by 74.78% to -$17.0 million in 2017.
  • Business Quant data shows Net Income towards Common Stockholders for TENX at -$17.0 million in Q4 2017, $1.3 million in Q3 2017, and $3.0 million in Q2 2017.